Pharmaceutical Executive - Pharmaceutical news and analysis. Pharma management, sales, marketing & finance

Supply Chain Strategy: Managing risk and opportunity in a changing global landscape
Sponsored By PricewaterhouseCoopers LLP Optimizing the Multi-Sponsor REMS Experience (Risk Evaluation & Mitigation Strategies)
Sponsored By PricewaterhouseCoopers LLP Effective Resource Planning: Reducing Clinical Project Risk and Operating Cost
Sponsored By ClearTrial
ARCHIVED WEBCASTS

Featured Q&A- Clinical Portals: Balancing Sponsor and Site Perspectives
A wrapup of the discussions at CBI's 3rd Summit on Clinical Trial Investigator Portals

Meet 2011's Emerging Pharma Leaders
VIEW PDF: Can these 30 trendsetters build competitive scale from scarcity?

PODCAST: Listen to audio interviews with 7 of the Emerging Pharma Leaders
sponsored by:

2011 Pharm Exec 50

Ranks the world's largest pharmaceutical companies by global sales of prescription drugs.
sponsored by:

Pharma Country Reports
Market reports on pharma developments worldwide
sponsored by:

Featured Jobs

More Jobs

New & Noteworthy

AstraZeneca's Real-World Bet

In establishing the value of new medicines, old-way theory is yielding to real-world practice — but there are risks in being 'of the moment'.

Pharma Worst Hit by 'Talent Crunch'

A recent global CEO report reveals that 51% of pharma CEOs think it has become more difficult to hire workers within the sector, outweighing the same problem in all other industries surveyed.

Managed Access in the UK: Meeting Unmet Need

Simon Estcourt assesses how the regulatory landscape for managed access programs is evolving, particularly in the UK.

Preparing For the New China

China's healthcare reforms are generating uncertainty for its domestic pharmaceutical market, writes Jon Zifferblatt.

More Selected Features

Europe

The Italian's Job — Guido Rasi's EMA Challenge

Europe's Economic Crisis: The Effect on Outsourcing to Emerging Markets

Industry/Gov't R&D Support: So Far So Good

Here's to a Happier New Year?

Europe Tackles 'Advertising in Disguise' Fears

Regulatory

FDA Unveils Guidance for Biosimilar Development

As the Compliance Net Tightens...

Costs and Benefits of Health Reform

FDA Social Media Guidelines: Irresponsible?

New Year, New Issues

More Regulatory

Deals

Pharm Exec's 2012 Pipeline Report

30 Years of Pharma: Perspective in Numbers, Part 3

30 Years of Pharma: Perspective in Numbers, Part 1

30 Years of Pharma: Perspective in Numbers, Part 2

Pharm Exec's 10th Annual Industry Audit

More Deals

Technology

Sales: Fully Mobilize Your Mobile Technology

iPad Apps: Are You Content with your Content?

Complex Biologics: The View from Teva

Innovating Around Innovation

Pharma and Social Media: Ready to Make Nice?

More Technology

GlaxoSmithKline Recalls Antihypertensive Drug Made at Novartis Facility

Rare Diseases Lead to Unique Legislation

Rare Disease Day: Spotlight on Solidarity

Onyx Bullish in 2012 Outlook

Combating Opioid Abuse With Science

Tasty Asian Acquisition for Publicis

More Blog Posts

Drug SafetyRodney L. LemeryWhere Does Data Stop and Information Begin?
Regulatory Amy RitterAct Aims to Accelerate Access to Treatments
EuropePeter O' DonnellWhat Europe's New Clinical Trial Rules Mean for Personalized Medicine
Guest Blog Stephanie SuttonThe West's Counterfeit Woes Continue

Survey

More Marketing

More Sales

PHARM EXEC GLOBAL DIGEST

Have you read the latest issue of Pharmaceutical Executive Digest Europe yet?
Click here if you haven't.Click here to receive the Digest into your inbox every week.

Whitepapers

Increasing Planning Efficiency in Clinical Development

How Customer Analytics Improve Profitability

Customer Intimacy: The Pharma Challenge

SAS® for Marketing Strategy and Planning

UPS Survey Unveils Healthcare Supply Chain Trends

More Whitepapers

SPONSORED LINKS